Does TAMSULOSIN Cause Hyperparathyroidism secondary? 26 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Hyperparathyroidism secondary have been filed in association with TAMSULOSIN (Tamsulosin Hydrochloride). This represents 0.2% of all adverse event reports for TAMSULOSIN.
26
Reports of Hyperparathyroidism secondary with TAMSULOSIN
0.2%
of all TAMSULOSIN reports
0
Deaths
26
Hospitalizations
How Dangerous Is Hyperparathyroidism secondary From TAMSULOSIN?
Of the 26 reports, 26 (100.0%) required hospitalization.
Is Hyperparathyroidism secondary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAMSULOSIN. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does TAMSULOSIN Cause?
Dizziness (1,736)
Dyspnoea (1,375)
Drug ineffective (1,005)
Fall (960)
Syncope (904)
Hypotension (896)
Fatigue (871)
Off label use (844)
Asthenia (701)
Headache (699)
What Other Drugs Cause Hyperparathyroidism secondary?
ESOMEPRAZOLE (1,357)
OMEPRAZOLE (1,274)
PANTOPRAZOLE (947)
LANSOPRAZOLE (888)
DEXLANSOPRAZOLE (382)
RABEPRAZOLE (108)
DENOSUMAB (60)
FUROSEMIDE (49)
OMEPRAZOLE\SODIUM BICARBONATE (48)
ESOMEPRAZOLE\NAPROXEN (47)
Which TAMSULOSIN Alternatives Have Lower Hyperparathyroidism secondary Risk?
TAMSULOSIN vs TAPENTADOL
TAMSULOSIN vs TAPINAROF
TAMSULOSIN vs TARCEVA
TAMSULOSIN vs TARLATAMAB
TAMSULOSIN vs TARLATAMAB-DLLE